strategies to assess minimal residual disease
Published 4 years ago • 76 plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
8:53
all: when and who to test for minimal residual disease
-
4:20
an overview of minimal residual disease testing
-
3:07
minimal residual disease (mrd)
-
3:19
what impact have new minimal residual disease (mrd) assessment techniques had in myeloma?
-
4:11
using ctcs to determine minimal residual disease in gi cancers
-
1:56:11
innovative solutions for diagnosis and minimal residual disease assessment in acute
-
2:26
dr. farhad ravandi on how to treat minimal residual disease
-
0:47
what is minimal residual disease & how is it used to inform treatment?
-
7:32
minimal residual disease in acute lymphoblastic leukemia
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
4:10
how does minimal residual disease (mrd) testing affect treatment decisions?
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?
-
4:47
how is minimal residual disease managed in patients with all?
-
3:21
is there a new highly sensitive blood test to detect minimal residual disease?
-
6:08
mrd assessment and its clinical implications in aml
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
6:22
minimum residual disease in acute lymphoblastic leukemia
-
58:32
significance of minimal residual disease in acute myeloid leukemia
-
1:28
mrd assessment and treatment tailoring